Tachyon Therapeutics

San Francisco, United States

Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.

$11.6M raised

Mar 2023

Series A

Biotechnology Health Care Life Science Medical

Top Investors

Khosla Ventures Red Tree Venture Capital California Institute for Regenerative Medicine Veblen Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tachyon Therapeutics

How much funding has Tachyon Therapeutics raised?

Tachyon Therapeutics has raised $11.6M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Who are Tachyon Therapeutics's investors?

Tachyon Therapeutics's investors include Khosla Ventures, Red Tree Venture Capital, California Institute for Regenerative Medicine, Veblen Ventures.

Where is Tachyon Therapeutics headquartered?

Tachyon Therapeutics is headquartered in San Francisco, United States.

What does Tachyon Therapeutics do?

Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.

What stage is Tachyon Therapeutics at?

Tachyon Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2023.

MLA

"Tachyon Therapeutics — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/tachyon-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). Tachyon Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tachyon-therapeutics

Wikipedia (cite web)

{{cite web |title=Tachyon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tachyon-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K